0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

The JAMA Forum |  FREE
Gail Wilensky, PhD
JAMA. 2016;316(1):21-22. doi:10.1001/jama.2016.8019.

Viewpoint | 
Laura L. Sessums, JD, MD; Sarah J. McHugh, MPH; Rahul Rajkumar, MD, JD
JAMA. 2016;315(24):2665-2666. doi:10.1001/jama.2016.4472.

News From the Centers for Disease Control and Prevention | 
JAMA. 2016;315(14):1444. doi:10.1001/jama.2016.3123.

Editorial | 
Howard Bauchner, MD; Phil B. Fontanarosa, MD; Robert M. Golub, MD
JAMA. 2016;315(11):1118-1119. doi:10.1001/jama.2016.2422.

Viewpoint | 
K. John McConnell, PhD
JAMA. 2016;315(9):869-870. doi:10.1001/jama.2016.0206.

Health Agencies Update | 
Julie A. Jacob, MA
JAMA. 2016;315(4):336. doi:10.1001/jama.2015.19189.

Viewpoint | 
Elizabeth A. McGlynn, PhD; Eve A. Kerr, MD, MPH
JAMA. 2016;315(2):129-130. doi:10.1001/jama.2015.16858.

Original Investigation |  FREE
Keith Van Haren, MD; Patrick Ayscue, DVM; Emmanuelle Waubant, MD, PhD; et al.
JAMA. 2015;314(24):2663-2671. doi:10.1001/jama.2015.17275.
Includes: Supplemental Content

Viewpoint | 
Rocco J. Perla, EdD; Bruce Finke, MD; Darren A. DeWalt, MD, MPH
JAMA. 2015;314(20):2131-2132. doi:10.1001/jama.2015.15079.
Includes: Supplemental Content

Health Agencies Update | 
Julie A. Jacob, MA
JAMA. 2015;314(16):1683. doi:10.1001/jama.2015.12840.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Editorial  | 
Contactin-Associated Protein-like 2 Antibodies Tackling the Issue of Syndrome Diversity
Christian G. Bien, MD
JAMA Neurology
Original Investigation  | 
Characterization of a Subtype of Autoimmune Encephalitis With Anti–Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures
Bastien Joubert, MD; Margaux Saint-Martin, MSc; Nelly Noraz, PhD; et al.
JAMA Neurology
Editorial  | 
Seronegative Myasthenia Gravis—A Vanishing Disorder?
Henry J. Kaminski, MD
JAMA Neurology
Original Investigation  | 
Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin
Elena Cortés-Vicente, MD; Eduard Gallardo, PhD; María Ángeles Martínez, BSc; et al.